Rothwell Investment Advisors, LLC’s United Therapeutics UTHR Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$387K	Buy	+715	New	+$370K	0.21%	95

Other funds holding UTHR

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Rothwell Investment Advisors, LLC's UTHR Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in United Therapeutics (UTHR) in Q3 2026: 715 shares worth $387K. The stake represents 0.21% of the portfolio and ranks #95 among its holdings.

390 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Rothwell Investment Advisors, LLC held 715 shares of United Therapeutics worth $387K as of Q3 2026.
United Therapeutics was a new Rothwell Investment Advisors, LLC position in Q3 2026.
United Therapeutics made up 0.21% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #95 holding.
390 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.